Visa heads into the week of October earnings with the stock down 3.6% and options traders showing their most bullish lean of the past year — a rare disconnect worth watching.
The clearest tension this week sits in the options market. The put/call ratio has dropped to 0.93, nearly two standard deviations below its 20-day mean of 1.01 — the most call-heavy reading in at least a year, against a 52-week PCR floor of 0.73. That shift is striking precisely because it arrives while the stock is selling off. Shares closed at $362.04 on September 22, down 2.1% on the day and off 2.4% over the past month. Options positioning and price action are pulling in opposite directions. Whether that reflects genuine conviction in a bounce, or simply mechanical call accumulation, is the central question for the setup.
The lending market offers no amplification of the bearish price move. Short interest is benign at 1.2% of the free float — a level that simply does not make a short-squeeze or short-covering story. Availability in the borrow pool is extraordinarily loose at over 3,000%, meaning there is roughly 30 shares available to lend for every one already borrowed. Cost to borrow has eased about 16% over the past week to 0.35%, the lowest reading in the 30-day window. The ORTEX short score holds at a steady 31.6, well below levels that would signal meaningful pressure building. Short sellers are not driving this story.
The Street's conviction on Visa remains directionally positive, though the gap between where analysts sit and where the stock trades is doing some of the talking. RBC Capital raised its target to $466 in late August while maintaining its Outperform rating. Wolfe Research followed shortly after, pushing its target to $460 from $435. Both moves came after the July quarterly results, which delivered 9% year-over-year payments volume growth and a 1.7% next-day stock reaction. The analyst consensus still implies roughly 15% upside from current levels, with the mean target around $418. Bulls point to low double-digit earnings growth guidance for fiscal 2026, strong international volumes, and lean incentive costs. Bears counter with a 32x P/E multiple, the threat from government-sponsored payment rails, and blockchain-adjacent disruptors — all of which are structural headwinds with long lead times but real optionality against Visa's toll-road model. The P/E has compressed roughly 1.7 turns over the past 30 days, narrowing to about 24.9x on trailing earnings, which takes some pressure off the valuation argument without resolving it.
Peer performance this week reinforces that payments broadly are under pressure, not just Visa. Mastercard fell 3.0% on the week — almost in lockstep with Visa's 3.6% decline and consistent with an 83% price correlation between the two names. FIS and Fiserv fared worse, dropping 6.4% and 7.8% respectively, suggesting the sector rotation is hitting lower-quality processing names harder. Marqeta was the outlier, adding 2.1% on the day, though it still closed the week down about 1%. The breadth of weakness across the group suggests macro pressure or sector rotation rather than anything Visa-specific.
On the insider front, all recent activity has been pre-arranged. CEO Ryan McInerney exercised and sold 5,875 shares on September 1 for roughly $2.2 million under a 10b5-1 plan, and General Counsel Julie Rottenberg ran similar paired exercise-and-sell transactions in September and August. The 90-day net is a $44.9 million net sale, but the structured nature of every trade here strips out most of the signalling value — these are compensation-mechanics transactions, not discretionary bets.
Earnings are due October 27. The last two prints produced muted reactions: plus 1.7% the day after July results and minus 2.0% after the April release. With next earnings five weeks out, the watch points are whether the PCR's sudden bullishness holds as the event approaches, and whether the Street's wide target premium over spot — roughly 15% at current prices — begins to attract buyers or simply marks an optimism overhang.
See the live data behind this article on ORTEX.
Open V on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
